Single-agent pegylated liposomal doxorubicin (Caelix®) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial
Keyword(s):
2011 ◽
Vol 20
(2)
◽
pp. 305-307
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):